Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Very difficult to be constructive

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Mar 01, 2022 3:38pm

234 Views

Post# 34472430

Very difficult to be constructive

Small cap, biotech, illiquid, no good news, frustration, no analyst or institutional support. That's the Thera failure legacy. Yep that's it.. next level 3$ or 2usd... Can't wait for this to be over among other things of course.. You guys should sell and go away, me I'm stuck in this sh.t, head deep in this sh.t of company.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market